...
首页> 外文期刊>Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry >Synthesis, Characterization and Crystal Structure of N-(4-(4-Fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide
【24h】

Synthesis, Characterization and Crystal Structure of N-(4-(4-Fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide

机译:N-(4-(4-氟苯基)-5-(羟甲基)-6-异丙基嘧啶-2-基)-N-甲基甲磺酰胺的合成,表征和晶体结构

获取原文
获取原文并翻译 | 示例
           

摘要

N-[4-(4-Fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl]-N-methylmethane sulfonamide (I), an important intermediate to synthesize rosuvastatin, an HMG-CoA reductase inhibitor. It was prepared from methyl 4-(4-fluorophenyl)-6-isopropyl-2-(methylamino)pyrimidine-5-carboxylate (1) via mesylation by mesyl chloride and sodium tert-pentoxide, then reduction by DIBAL/HCl. The product was characterized by NMR and LC-MS. The crystal structure of compound I was investigated using X-ray diffraction and SHELXTL-97 software. The result indicated that compound I crystallized in the monoclinic system, space group C2/C with a = 29.683(6), b = 7.6290 (15), c= 18.215(4) A. V = 3451.1 (16)A~3; Z8.
机译:N- [4-(4-氟苯基)-5-(羟甲基)-6-异丙基嘧啶-2-基] -N-甲基甲烷磺酰胺(I),是合成瑞舒伐他汀(HMG-CoA还原酶抑制剂)的重要中间体。由4-(4-氟苯基)-6-异丙基-2-(甲基氨基)嘧啶-5-羧酸甲酯(1)经甲磺酰氯和叔五氧化钠甲磺酰化,然后经DIBAL / HCl还原制得。产物通过NMR和LC-MS表征。使用X射线衍射和SHELXTL-97软件研究了化合物I的晶体结构。结果表明,化合物Ⅰ在单斜晶系C2 / C空间群中结晶,其a = 29.683(6),b = 7.6290(15),c = 18.215(4)A。V= 3451.1(16)A〜3。 Z8。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号